Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

131.2K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.2K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

367
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
367
Depression: Overview01:18

Depression: Overview

678
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
678
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

468
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
468
Neurotransmitters01:31

Neurotransmitters

2.5K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
2.5K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

284
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
284

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and Sociodemographic Correlates of Poor Medication Adherence in People With Bipolar Disorder: A Systematic Review and Meta-Analysis.

Bipolar disorders·2026
Same author

Efficacy of sertraline combined with low-dose antipsychotics in first-episode schizophrenia.

European archives of psychiatry and clinical neuroscience·2026
Same author

Is Happiness a Possible Outcome for People With Schizophrenia?

Alpha psychiatry·2026
Same author

Complete blood count-based inflammatory ratios in people with bipolar disorder: a systematic review and meta-analysis of neutrophil-to-lymphocyte, monocyte-to-lymphocyte, and platelet-to-lymphocyte ratios.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

British journal of pharmacology·2025
Same author

Artificial Intelligence and Bipolar Disorder: Applications of Machine Learning Models for Diagnosis, Treatment, and Outcome Prediction.

Alpha psychiatry·2025

Related Experiment Video

Updated: Dec 26, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

455

Purinergic Signaling and Related Biomarkers in Depression.

Francesco Bartoli1,2, Geoffrey Burnstock3, Cristina Crocamo1

  • 1Department of Medicine and Surgery, University of Milano Bicocca, Via Cadore 48, 20900 Monza, Italy.

Brain Sciences
|March 18, 2020
PubMed
Summary

The purinergic system, involving adenosine and ATP signaling, is linked to depression. Targeting specific receptors like A2A and P2X7, and monitoring metabolites like uric acid, shows promise for depression treatment and biomarkers.

Keywords:
ATPadenosinebiomarkerscaffeinedepressionmolecular psychiatrypurinergic system

More Related Videos

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.0K
The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

39.4K

Related Experiment Videos

Last Updated: Dec 26, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

455
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

8.0K
The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

39.4K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Purinergic signaling regulates key physiological functions, including neurotransmission and neuromodulation.
  • The purinergic system is implicated in the pathophysiology of mood disorders, affecting neurotransmitter and hormonal pathways.
  • Mood disorder treatments can alter purinergic signaling, suggesting a therapeutic link.

Purpose of the Study:

  • To explore the biological basis connecting the purinergic system to depression.
  • To review evidence for the antidepressant effects of purinergic modulators.
  • To identify potential purinergic targets and biomarkers for depression.

Main Methods:

  • Review of preclinical and clinical studies on purinergic signaling in depression.
  • Analysis of adenosine (P1) and ATP (P2) receptor-mediated signaling.
  • Investigation of purinergic metabolites, such as serum uric acid, as biomarkers.

Main Results:

  • Adenosine and ATP signaling via P1 and P2 receptors may be altered in depression.
  • Caffeine (adenosine antagonist) and other purinergic modulators show potential antidepressant effects.
  • A2A and P2X7 receptors are identified as potential therapeutic targets, with antagonists demonstrating antidepressant effects in preclinical studies.
  • Peripheral purinergic metabolites, including serum uric acid, may serve as depression biomarkers.

Conclusions:

  • The purinergic system offers a promising avenue for understanding the molecular underpinnings of depression.
  • Targeting A2A and P2X7 receptors and utilizing purinergic metabolites could lead to novel depression treatments and diagnostic tools.